Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
03/2012
03/08/2012WO2011132955A3 Use of hades as tumor suppressor target
03/08/2012WO2011130476A3 Polymer-based therapeutic agents
03/08/2012WO2011130434A3 Antibodies that bind human cd27 and uses thereof
03/08/2012WO2011130249A3 Methods and compositions for inhibition of treg cells
03/08/2012WO2011129936A9 Compositions and methods for the prevention and treatment of cancer
03/08/2012WO2011118994A9 Nlk as a marker for diagnosis of liver cancer and as a therapeutic agent thereof
03/08/2012WO2011096756A9 Pharmaceutical composition for inhibiting abnormal proliferation of cells
03/08/2012WO2011090349A9 Nanocarrier having enhanced skin permeability, cellular uptake and tumour delivery properties
03/08/2012WO2001000832A9 Methods for making apo-2 ligand using divalent metal ions
03/08/2012US20120059240 Method for preparation of micellar hybrid nanoparticles for therapeutic and diagnostic applications and compositions thereof
03/08/2012US20120059151 Non-Functional P2X7 Receptor
03/08/2012US20120059061 Novel anti-inflammatory compounds
03/08/2012US20120059052 Prenylflavonoid formulations
03/08/2012US20120059050 Garcinia derivative, its preparing method and medicinal use
03/08/2012US20120059048 METHODS FOR DIAGNOSING AND TREATING SQUAMOUS CELL CARCINOMA UTILIZING miRNA-205 AND INHIBITORS THEREOF
03/08/2012US20120059046 Inhibition of map4k4 through rnai
03/08/2012US20120059044 Methods of utilizing the arrestin-2/stam-1 complex as a therapeutic target
03/08/2012US20120059043 Therapeutic and diagnostic strategies
03/08/2012US20120059032 1,2,3,4-tetrahydroisoquinoline derivatives effective as antiglioma agents, methods of making, and their use
03/08/2012US20120059029 Selective integrin inhibitors
03/08/2012US20120059021 Compositions and methods for treating cancer and methods for predicting a response to such treatments
03/08/2012US20120059018 Novel chlorin e6-folic acid conjugate, preparation method thereof, and a pharmaceutical composition for the treatment of cancer comprising the same
03/08/2012US20120059017 CGRP Receptor Antagonist
03/08/2012US20120059016 Piperidine and piperazine derivatives as autotaxin inhibitors
03/08/2012US20120059009 Anti-tumor agent containing tegafur-gimeracil-oteracil potassium combination drug and oxaliplatin
03/08/2012US20120059005 Combination of (a) a phosphoinositide 3-kinase inhibitor and (b) an antidiabetic compound for use in the treatment of proliferative diseases
03/08/2012US20120059004 Compounds And Compositions For Treating Cancer
03/08/2012US20120059003 Inhibitors of inv(16) leukemia
03/08/2012US20120059001 Novel kinase modulators
03/08/2012US20120059000 Chemical compounds, compositions and methods for kinase modulation
03/08/2012US20120058997 Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinase inhibitors
03/08/2012US20120058995 Methods of chemical synthesis of diaminophenothiazinium compounds involving the use of persulfate oxidants
03/08/2012US20120058991 Formulations and Methods of Administration of Cephalotaxines, Including Homoharringtonine
03/08/2012US20120058988 Carbazole and carboline kinase inhibitors
03/08/2012US20120058985 Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activities
03/08/2012US20120058982 Analogs of Benzoquinone-Containing Ansamycins and Methods of Use Thereof
03/08/2012US20120058981 Androgen pharmaceutical composition and method for treating depression
03/08/2012US20120058978 Method for the treatment of central nervous system cancers and compositions related thereto
03/08/2012US20120058975 Phosphonate Compounds
03/08/2012US20120058971 Cyclodextrin-based polymers for therapeutic delivery
03/08/2012US20120058966 Sphingosine Kinase Inhibitor Prodrugs
03/08/2012US20120058961 Pharmaceutical Composition for Treating Cancers
03/08/2012US20120058960 Feedback prodrug
03/08/2012US20120058954 Diaza Heterocyclic Compounds for Phototherapy
03/08/2012US20120058953 Compositions and methods for enhancing apoptosis
03/08/2012US20120058208 Synergistic Composition for Enhancing Bioavailability of Curcumin
03/08/2012US20120058204 Use of over expression of cystathionine gamma lyase as a prognostic, diagnostic and therapeutic target for cancer
03/08/2012US20120058203 Methods for treating cancer and other pathological proliferating disorders by inhibiting mitosis using pyrrolo[2,3-d]pyrimidines
03/08/2012US20120058202 Means and Method for Ovarian Cancer Prognosis
03/08/2012US20120058199 Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin
03/08/2012US20120058191 Carbon-bearing nsp3 nanoparticle and its synthesis route
03/08/2012US20120058180 Liver-specific Nanocapsules and Methods of Using
03/08/2012US20120058178 Liposome Composition
03/08/2012US20120058177 Nanoparticle-based tumor-targeted drug delivery
03/08/2012US20120058150 Methods for Delivering Compositions by Electrospraying a Medical Device
03/08/2012US20120058144 Lipids and compositions for the delivery of therapeutics
03/08/2012US20120058141 Chimeric newcastle disease viruses and uses thereof
03/08/2012US20120058138 Novel Adenovirus Vectors
03/08/2012US20120058137 Efficient transport into white blood cells
03/08/2012US20120058131 Pta089 protein
03/08/2012US20120058130 Compositions and methods for diagnosing, treating, and preventing prostate conditions
03/08/2012US20120058128 Anti- integrin antibodies, compositions, methods and uses
03/08/2012US20120058126 Anti-vegfr-3 antibody compositions
03/08/2012US20120058122 Antibodies Directed to HER-3 and Uses Thereof
03/08/2012US20120058120 Targets for Growth Factor Signalling and Methods of Therapy
03/08/2012US20120058119 Human tumor necrosis factor tr21 and methods based thereon
03/08/2012US20120058117 Neuropilin-1 inhibitors
03/08/2012US20120058114 ERBB2 antibodies comprising modular recognition domains
03/08/2012US20120058113 Cancer treatment method
03/08/2012US20120058108 Methods and uses involving genetic aberrations of nav3 and aberrant expression of multiple genes
03/08/2012US20120058107 Pyrrolo [3,2-c] pyridine-4-one 2-indolinone protein kinase inhibitors
03/08/2012US20120058106 Novel cancer-associated antigen
03/08/2012US20120058102 Pharmacologically induced transgene ablation system
03/08/2012US20120058100 Modulation of drug release rate from electrospun fibers
03/08/2012US20120058088 Resveratrol-Containing Compositions And Methods Of Use
03/08/2012US20120058082 Methods and compositions for treatment
03/08/2012US20120058079 1,2,5-Oxadiazoles as Inhibitors of Indoleamine 2,3-Dioxygenase
03/08/2012US20120058055 Gastrorententive oral high dose zinc preparations
03/08/2012US20120058054 Gadolinium complex, method for preparing same, and mri contrast agent comprising same
03/08/2012US20120058051 Anti-human ror1 antibodies
03/08/2012US20120058048 Directed radiotherapy
03/08/2012US20120058047 Method of using an anti-cd137 antibody as an agent for radioimmunotherapy or radioimmunodetection
03/08/2012CA2847413A1 Vesicular stomatitis viruses
03/08/2012CA2810217A1 Anti-cxcl13 antibodies and methods of using the same
03/08/2012CA2810171A1 Antibodies that bind to adrenomedullin and to adrenomedullin receptors and the uses thereof as drugs
03/08/2012CA2810049A1 Guanidine compounds and compositions for the inhibition of nampt
03/08/2012CA2810038A1 Novel compounds and compositions for the inhibition of nampt
03/08/2012CA2810024A1 Quinazoline compounds and methods of use thereof
03/08/2012CA2809994A1 An optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof
03/08/2012CA2809993A1 An optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof
03/08/2012CA2809983A1 Hydrobromide salts of a pyrazolylaminoquinazoline
03/08/2012CA2809979A1 Compositions and methods for modulating emt and uses thereof
03/08/2012CA2809934A1 Process for producing drug-block copolymer composite and pharmaceutical preparation containing same
03/08/2012CA2809892A1 Pyrazolopyridinone derivatives as lpa receptor antagonists
03/08/2012CA2809836A1 Pyridinones/pyrazinones, method of making, and method of use thereof
03/08/2012CA2809677A1 Anti-c-met antibody and methods of use thereof
03/08/2012CA2809662A1 Pyridazinones, method of making, and method of use thereof
03/08/2012CA2809617A1 Nanoparticle-based tumor-targeted drug delivery
03/08/2012CA2809553A1 Imidazo[4,5-c]quinolines as dna-pk inhibitors
03/08/2012CA2809493A1 Peptide or peptide complex binding to .alpha.2 integrin and methods and uses involving the same
1 ... 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 ... 2211